Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study
(2010) 52nd Annual Meeting of the American-Society-of-Hematology (ASH) In Blood 116(21). p.1281-1281
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1917858
- author
- organization
- publishing date
- 2010
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Blood
- volume
- 116
- issue
- 21
- pages
- 1281 - 1281
- publisher
- American Society of Hematology
- conference name
- 52nd Annual Meeting of the American-Society-of-Hematology (ASH)
- conference dates
- 2010-12-04 - 2010-12-07
- external identifiers
-
- wos:000285025203439
- ISSN
- 1528-0020
- language
- English
- LU publication?
- yes
- id
- a88db225-f704-4026-94f1-b13b30741621 (old id 1917858)
- date added to LUP
- 2016-04-01 10:48:30
- date last changed
- 2018-11-21 19:51:10
@misc{a88db225-f704-4026-94f1-b13b30741621, author = {{Koivula, Satu and Taskinen, Minna and Chen, Ping and Holte, Harald and Delabie, Jan and Lindsberg, Marja Liisa Karjalainen and Bjorkholm, Magnus and Fluge, Oystein and Pedersen, Lars Moller and Jerkeman, Mats and Eriksson, Mikael and Hautaniemi, Sampsa and Leppa, Sirpa}}, issn = {{1528-0020}}, language = {{eng}}, note = {{Conference Abstract}}, number = {{21}}, pages = {{1281--1281}}, publisher = {{American Society of Hematology}}, series = {{Blood}}, title = {{Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study}}, volume = {{116}}, year = {{2010}}, }